Notable Analyst Rating Changes 08/24: (USG) (TCB) (BMY) Upgraded; (ADSK) (GGP) (BIG) Downgraded
Tweet
Share
E-mail
Get Alerts USG Hot Sheet
Join SI Premium – FREE
UPGRADES
Longbow Research raises USG Corp. (NYSE: USG) from Neutral to Buy, moving its price target from $20 up to $26.
BMO Capital boosts TCF Financial (NYSE: TCB) from Market Perform to Outperform with a price target of $13.
BofA/Merrill Lynch upgrades Bristol-Myers Squibb Co. (NYSE: BMY) from Neutral to Buy.
Goldman Sachs raises Frontline Ltd. (NYSE: FRO) from Sell to Neutral. Click Here for more color.
For daily real-time Upgrades go to http://www.streetinsider.com/Upgrades
DOWNGRADES
Three firms cut ratings on Autodesk (Nasdaq: ADSK):
Benchmark lowers Big Lots (NYSE: BIG) from Buy to Hold with a price target of $33. Click Here for more color.
Morgan Stanley cuts Staples, Inc. (Nasdaq: SPLS) from Overweight to Equalweight.
For daily real-time Downgrades go to http://www.streetinsider.com/downgrades
NEW COVERAGE
ThinkEquity starts PDL BioPharma (Nasdaq: PDLI) with a Hold and $7 target.
Stifel Nicolaus assumes Threshold Pharmaceuticals (Nasdaq: THLD) at Buy and $13 price target.
Barclays resumes Kinder Morgan (NYSE: KMI) at Overweight and $40 target.
William Blair begins VirnetX Holding (NYSE: VHC) with an Outperform.
For daily real-time New Coverage go to http://www.streetinsider.com/New+Coverage
Visit our new Ratings Insider portal to get the most comprehensive and up-to-date analyst coverage on the Street.
Longbow Research raises USG Corp. (NYSE: USG) from Neutral to Buy, moving its price target from $20 up to $26.
BMO Capital boosts TCF Financial (NYSE: TCB) from Market Perform to Outperform with a price target of $13.
BofA/Merrill Lynch upgrades Bristol-Myers Squibb Co. (NYSE: BMY) from Neutral to Buy.
Goldman Sachs raises Frontline Ltd. (NYSE: FRO) from Sell to Neutral. Click Here for more color.
For daily real-time Upgrades go to http://www.streetinsider.com/Upgrades
DOWNGRADES
Three firms cut ratings on Autodesk (Nasdaq: ADSK):
- BofA/Merrill Lynch from Neutral to Underperform;
- JPMorgan from Overweight to Neutral, moving its price target from $43 down to $32.50; and
- Canaccord Genuity from Buy to Hold, dropping its price target to $32, from $47 prior. Click Here for more color.
Benchmark lowers Big Lots (NYSE: BIG) from Buy to Hold with a price target of $33. Click Here for more color.
Morgan Stanley cuts Staples, Inc. (Nasdaq: SPLS) from Overweight to Equalweight.
For daily real-time Downgrades go to http://www.streetinsider.com/downgrades
NEW COVERAGE
ThinkEquity starts PDL BioPharma (Nasdaq: PDLI) with a Hold and $7 target.
Stifel Nicolaus assumes Threshold Pharmaceuticals (Nasdaq: THLD) at Buy and $13 price target.
Barclays resumes Kinder Morgan (NYSE: KMI) at Overweight and $40 target.
William Blair begins VirnetX Holding (NYSE: VHC) with an Outperform.
For daily real-time New Coverage go to http://www.streetinsider.com/New+Coverage
Visit our new Ratings Insider portal to get the most comprehensive and up-to-date analyst coverage on the Street.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA Securities Starts Mobility Global (MBGL) at Neutral
- BofA says momentum style supported by earnings revisions
- Walmart (WMT) PT Lowered to $126 at BofA Securities
Create E-mail Alert Related Categories
Special ReportsRelated Entities
Stifel, UBS, William Blair, JPMorgan, Morgan Stanley, ThinkEquity, BMO Capital, Barclays, Longbow Research, Notable Analyst Rating Changes, Canaccord GenuitySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
